BEVERLY TOMASETTI: Open Payments
NPI 1700901170 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 33 payments from 13 companies in 2025. Trend: 2023 $954 · 2024 $1,073 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $344 |
| Janssen Biotech, Inc. | 6 | $128 |
| Sumitomo Pharma America, Inc. | 5 | $95 |
| ConvaTec Inc. | 2 | $76 |
| ABBVIE INC. | 2 | $47 |
| Teleflex LLC | 2 | $43 |
| Astellas Pharma US Inc | 1 | $23 |
| Boston Scientific Corporation | 1 | $22 |
| COLOPLAST CORP | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Xofigo, ERLEADA, GEMTESA, GENTLECATH GLIDE, Nubeqa, LUPRON DEPOT, BARRIGEL, XTANDI.
Industry payments across PA — which companies pay providers there.
